Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Regular bedtimes linked to better language, reading and math skills in preschool children

June 6, 2010 9:38 pm | by EurekAlert | News | Comments

(American Academy of Sleep Medicine) Children in households with bedtime rules and children who get adequate sleep scored higher on a range of developmental assessments. Scores for receptive and expressive language, phonological awareness, literacy and early math abilities were...

TOPICS:

Study is first to find that CPAP therapy restores brain tissue in adults with sleep apnea

June 6, 2010 9:36 pm | by EurekAlert | News | Comments

(American Academy of Sleep Medicine) Obstructive sleep apnea patients had reductions of gray-matter volume at baseline but showed significant gray-matter volume increase after three months of CPAP therapy. No further improvement in gray-matter volume was observed after one year of...

TOPICS:

Study finds a seasonal variance in sleep-disordered breathing in young children

June 6, 2010 9:36 pm | by EurekAlert | News | Comments

(American Academy of Sleep Medicine) In summer and fall the prevalence of mild sleep-disordered breathing in elementary-school children increased steadily from June (21.6 percent) through September (37.2 percent) and then decreased from September through November (6.3 percent)....

TOPICS:
Advertisement

The $30 Genome?

June 6, 2010 8:41 pm | by Massachusetts Institute of Technology | News | Comments

A startup is developing a new and potentially much cheaper sequencing technology based on microfluidics.

Brain scan 'lie detector' warning

June 6, 2010 3:40 pm | by BBC | News | Comments

Measures are needed to stop brain scans being misused by courts, insurers and employers, experts are warning.

TOPICS:

Chester A. Mathis receives SNM's 2010 Aebersold Award

June 6, 2010 7:36 am | by EurekAlert | News | Comments

(Society of Nuclear Medicine) Chester A. Mathis, Ph.D., director of the PET facility in the department of radiology at the University of Pittsburgh, has been named as this year's recipient of the prestigious Paul C. Aebersold Award. Mathis was presented the award by SNM -- a...

TOPICS:

Bengt Roland Långström receives SNM's 2010 Georg Charles de Hevesy Nuclear Pioneer Award

June 6, 2010 7:36 am | by EurekAlert | News | Comments

(Society of Nuclear Medicine) Bengt Roland Långström, Ph.D., a professor in the department of biochemistry and organic chemistry at Uppsala University in Sweden, has been named as this year's recipient of the Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to...

TOPICS:

New treatment regimen shown effective against advanced ovarian cancer

June 6, 2010 5:38 am | by EurekAlert | News | Comments

(Fox Chase Cancer Center) Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends...

TOPICS:
Advertisement

Poniard Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer

June 5, 2010 4:37 pm | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO , June 5 /- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced the full efficacy and safety data from its Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial of picoplatin in...

TOPICS:

Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer

June 5, 2010 11:38 am | by Bio-Medicine.Org | News | Comments

CHICAGO , June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer...

TOPICS:

Second-line CML drugs evoke faster, better front-line remissions

June 5, 2010 6:38 am | by EurekAlert | News | Comments

(University of Texas M. D. Anderson Cancer Center) Separate international phase III clinical trials compared high-quality remissions between previously untreated CML patients who took the standard-of-care drug imatinib and those on the second-generation drugs dasatinib and...

TOPICS:

Selenium shows no benefit in prevention of lung cancer

June 5, 2010 5:38 am | by EurekAlert | News | Comments

(University of Texas M. D. Anderson Cancer Center) Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer -- either a recurrence or...

TOPICS:

Ostendo & Oxford Instruments-TDI now offering semi-polar GaN wafers for LED & LD device makers

June 4, 2010 11:41 pm | by I-Micronews | News | Comments

Ostendo Technologies of Carlsbad, California and Technologies and Devices International, Inc. (TDI) of Oxfordshire, UK., part of the Oxford Instruments Group, have announced the availability of Semi-Polar (11-22) GaN layer on sapphire substrate wafers using Ostendo's proprietary design...

Unidym and Tokyo Electron begin joint program to develop large scale manufacturing equipment for printable carbon nanotube-based displays and solar cells

June 4, 2010 11:40 pm | by I-Micronews | News | Comments

Unidym, a majority owned subsidiary of Arrowhead Research (NASDAQ:ARWR) announced today that it has finalized an agreement with Tokyo Electron (TEL) to develop manufacturing equipment for carbon nanotube based displays and solar cells. TEL is the second largest semiconductor production...

Nasendoscopy proves useful in predicting treatment success in sleep apnea patients

June 4, 2010 9:40 pm | by EurekAlert | News | Comments

(American Academy of Sleep Medicine) Japan-based research shows that nasendoscopy may help dentists predict oral appliance therapy success in sleep apnea patients.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading